WHO ICTRP trial
Rheumatoid Arthritis Patients rePort Onset Reactivation
NL-OMON30946 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON30946 |
|---|---|
| Public title | Rheumatoid Arthritis Patients rePort Onset Reactivation |
| Scientific title | Rheumatoid Arthritis Patients rePort Onset Reactivation - RApport |
| Primary sponsor | Erasmus MC, Universitair Medisch Centrum Rotterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Countries | The Netherlands |
| Conditions | arthritis rheumatoid arthritis;10023213;arthritis;rheumatoid arthritis |
| Interventions | ;cohort;rheumatoid arthritis;self-reported questionnaires;validation |
| Registration date | Dec 17, 2007 |
| Target size | 150 |
| Secondary IDs | NL19149.078.07 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: